JAMA Ophthalmology : Randomized Trial of Anti-VEGF to Prevent Proliferative Diabetic Retinopathy (PDR) and Diabetic Macular Edema (DME)
Interview with Raj K Maturi, MD, and Jennifer K Sun, MD, authors of Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial and with Howard Bauchner, MD, Editor in Chief of JAMA (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - March 30, 2021 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Coronapod: Why COVID antibody treatments may not be the answer
In the early days of the pandemic, researchers raced to identify the most potent antibodies produced by the immune system in response to SAR-COV-2 infection and produce them in bulk. The resulting ‘monoclonal antibodies’ have since been tested in a variety of settings as treatments for COVID-19.But despite promising clinical trial results and several therapies having already been approved, antibody therapies have not yet played a large role in the fight against COVID-19. In this episode of Coronapod, we ask why.News: COVID antibody treatments show promise for preventing severe diseaseNews: Antibody therapi...
Source: Nature Podcast - March 19, 2021 Category: Science Authors: Springer Nature Limited Source Type: podcasts
Coronapod: Why COVID antibody treatments may not be the answer
In the early days of the pandemic, researchers raced to identify the most potent antibodies produced by the immune system in response to SAR-COV-2 infection and produce them in bulk. The resulting ‘monoclonal antibodies’ have since been tested in a variety of settings as treatments for COVID-19.But despite promising clinical trial results and several therapies having already been approved, antibody therapies have not yet played a large role in the fight against COVID-19. In this episode of Coronapod, we ask why.News: COVID antibody treatments show promise for preventing severe diseaseNews: Antibody therapi...
Source: Nature Podcast - March 19, 2021 Category: Science Authors: Springer Nature Limited Source Type: podcasts
TWiV 730: COVID-19 clinical update #53 with Dr. Daniel Griffin
In COVID-19 clinical update #53, Daniel Griffin reviews underreporting of infections and long term disease in children, a blood test for T cells, results of phase 3 trials for monoclonal antibodies, preliminary findings on an oral antiviral, clinical trial of ivermectin, and recommendations for upcoming gatherings. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode SARS-CoV-2 seroprevalence in (Source: This Week in Virology - MP3 Edition)
Source: This Week in Virology - MP3 Edition - March 13, 2021 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
JAMA Surgery : Clear vs Standard Covered Masks on Communication With Patients During Surgical Clinic Encounters
Interview with Muneera R. Kapadia, MD, and Ian M. Kratzke, authors of Effect of Clear vs Standard Covered Masks on Communication With Patients During Surgical Clinic Encounters: A Randomized Clinical Trial (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - March 11, 2021 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Stephen Thomas - Behind the scenes in the Pfizer vaccine trial
Never has the spotlight been as strong on a clinical trial as that on the Pfizer BioNTech vaccine, the first approved for covid-19.
In this interview, Joanne Silberner spoke to its lead principal investigator, Stephen Thomas chief of infectious diseases at SUNY Upstate Medical University, New York, became the lead principal investigator for one of the most closely watched clinical trials in history.
They discuss the moment th e positive results came through, what will happen to the people who are still enrolled in the trial, but got a placebo dose, and why the trial was designed in the way it was.www.bmj.com/coronavirus...
Source: The BMJ Podcast - March 8, 2021 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Stephen Thomas - Behind the scenes in the Pfizer vaccine trial
Never has the spotlight been as strong on a clinical trial as that on the Pfizer BioNTech vaccine, the first approved for covid-19.
In this interview, Joanne Silberner spoke to its lead principal investigator, Stephen Thomas chief of infectious diseases at SUNY Upstate Medical University, New York, became the lead principal investigator for one of the most closely watched clinical trials in history.
They discuss the moment the positive results came through, what will happen to the people who are still enrolled in the trial, but got a placebo dose, and why the trial was designed in the way it was.
www.bmj.com/coronaviru...
Source: The BMJ Podcast - March 8, 2021 Category: General Medicine Authors: BMJ Group Source Type: podcasts
JAMA Ophthalmology : Overminus Lens Therapy for Children 3 to 10 Years of Age With Intermittent Exotropia
Interview with Angela Chen, OD, MS, author of Overminus Lens Therapy for Children 3 to 10 Years of Age With Intermittent Exotropia: A Randomized Clinical Trial (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - March 4, 2021 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
What are the benefits and risks of using a tourniquet in knee replacement surgery?
The Cochrane Musculoskeletal Group has produced more than 200 reviews of a very wide range of interventions for patients with musculoskeletal problems. In this podcast, senior author Peter Wall, talks with Imran Ahmed, Trainee Orthopaedic Surgeon and NIHR Doctoral Researcher at Warwick Clinical Trials Unit and University Hospitals Coventry and Warwickshire NHS Trust in the UK about their December 2020 review of the effects of using a tourniquet in knee replacement surgery. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - March 2, 2021 Category: General Medicine Authors: Cochrane Source Type: podcasts
JAMA Cardiology : Screening for Atrial Fibrillation in the Older Population
Interview with Jeffrey Healey, MD, MSc, FRCPC, author of Screening for Atrial Fibrillation in the Older Population: A Randomized Clinical Trial, and Roopinder K. Sandhu, MD, MPH, author of Screening the Older Population for Atrial Fibrillation—Have We Moved the Needle Forward? (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - February 24, 2021 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
TWiV 721: COVID-19 clinical update #50 with Dr. Daniel Griffin
In COVID-19 clinical update #50, Daniel Griffin discusses CDC guidance on school opening, decreased viral load after vaccination, randomized clinical trial of vitamin D treatment, a study of zinc plus vitamin C, anticoagulation therapy effect on mortality, and multi system inflammatory phase in children. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Guidance on school openings (CDC) Calcifediol Treatment and COVID-19 (Lancet preprints) Zinc and vitamin C for COVID-19 (JAMA) Early anticoagulant therapy (BMJ) Multisys...
Source: This Week in Virology - MP3 Edition - February 20, 2021 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
